img

Global Ropivacaine Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ropivacaine Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Ropivacaine injection is used to cause numbness or loss of feeling in patients before and during surgery or labor and delivery. It is also used to relieve acute pain. Ropivacaine is a local anesthetic and does not cause loss of consciousness.
Ropivacaine Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ropivacaine Injection market is projected to reach US$ 1973.3 million in 2029, increasing from US$ 870 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2029. Demand from Surgical Anesthesia and Major Nerve Block are the major drivers for the industry.
Anesthetics are an indispensable class of important chemical substances in modern clinical surgery. The mechanism of action is to inhibit and block the conduction of nerve impulses. It plays an important role in alleviating the pain of patients and promoting the development of surgical medicine. With the development of medicine, more attention is paid to the patient's somatosensory, and the increase of painless surgery has promoted this market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ropivacaine Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Akorn
Anant Pharmaceuticals
SGPharma
Nephron Pharmaceuticals
Sintetica SA
AstraZeneca
Manus Aktteva Biopharma LLP
Zhejiang Xianju Pharmaceutical Co.,Ltd
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Yangzi River Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
Segment by Type
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
10 mg/mL (1%)

Segment by Application


Surgical Anesthesia
Major Nerve Block
Acute Pain Management
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ropivacaine Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ropivacaine Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ropivacaine Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ropivacaine Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ropivacaine Injection introduction, etc. Ropivacaine Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ropivacaine Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Ropivacaine Injection Market Overview
1.1 Ropivacaine Injection Product Overview
1.2 Ropivacaine Injection Market Segment by Type
1.2.1 2 mg/mL (0.2%)
1.2.2 5 mg/mL (0.5%)
1.2.3 7.5 mg/mL (0.75%)
1.2.4 10 mg/mL (1%)
1.3 Global Ropivacaine Injection Market Size by Type
1.3.1 Global Ropivacaine Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Ropivacaine Injection Historic Market Size Review by Type (2018-2024)
1.3.3 Global Ropivacaine Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ropivacaine Injection Sales Breakdown by Type (2018-2024)
1.4.2 Europe Ropivacaine Injection Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Ropivacaine Injection Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Ropivacaine Injection Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Ropivacaine Injection Sales Breakdown by Type (2018-2024)
2 Global Ropivacaine Injection Market Competition by Company
2.1 Global Top Players by Ropivacaine Injection Sales (2018-2024)
2.2 Global Top Players by Ropivacaine Injection Revenue (2018-2024)
2.3 Global Top Players by Ropivacaine Injection Price (2018-2024)
2.4 Global Top Manufacturers Ropivacaine Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ropivacaine Injection Market Competitive Situation and Trends
2.5.1 Ropivacaine Injection Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Ropivacaine Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ropivacaine Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Ropivacaine Injection Market
2.8 Key Manufacturers Ropivacaine Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ropivacaine Injection Status and Outlook by Region
3.1 Global Ropivacaine Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ropivacaine Injection Historic Market Size by Region
3.2.1 Global Ropivacaine Injection Sales in Volume by Region (2018-2024)
3.2.2 Global Ropivacaine Injection Sales in Value by Region (2018-2024)
3.2.3 Global Ropivacaine Injection Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Ropivacaine Injection Forecasted Market Size by Region
3.3.1 Global Ropivacaine Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Ropivacaine Injection Sales in Value by Region (2024-2029)
3.3.3 Global Ropivacaine Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ropivacaine Injection by Application
4.1 Ropivacaine Injection Market Segment by Application
4.1.1 Surgical Anesthesia
4.1.2 Major Nerve Block
4.1.3 Acute Pain Management
4.1.4 Other
4.2 Global Ropivacaine Injection Market Size by Application
4.2.1 Global Ropivacaine Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Ropivacaine Injection Historic Market Size Review by Application (2018-2024)
4.2.3 Global Ropivacaine Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ropivacaine Injection Sales Breakdown by Application (2018-2024)
4.3.2 Europe Ropivacaine Injection Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Ropivacaine Injection Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Ropivacaine Injection Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Ropivacaine Injection Sales Breakdown by Application (2018-2024)
5 North America Ropivacaine Injection by Country
5.1 North America Ropivacaine Injection Historic Market Size by Country
5.1.1 North America Ropivacaine Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ropivacaine Injection Sales in Volume by Country (2018-2024)
5.1.3 North America Ropivacaine Injection Sales in Value by Country (2018-2024)
5.2 North America Ropivacaine Injection Forecasted Market Size by Country
5.2.1 North America Ropivacaine Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Ropivacaine Injection Sales in Value by Country (2024-2029)
6 Europe Ropivacaine Injection by Country
6.1 Europe Ropivacaine Injection Historic Market Size by Country
6.1.1 Europe Ropivacaine Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ropivacaine Injection Sales in Volume by Country (2018-2024)
6.1.3 Europe Ropivacaine Injection Sales in Value by Country (2018-2024)
6.2 Europe Ropivacaine Injection Forecasted Market Size by Country
6.2.1 Europe Ropivacaine Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Ropivacaine Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Ropivacaine Injection by Region
7.1 Asia-Pacific Ropivacaine Injection Historic Market Size by Region
7.1.1 Asia-Pacific Ropivacaine Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ropivacaine Injection Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Ropivacaine Injection Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Ropivacaine Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Ropivacaine Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ropivacaine Injection Sales in Value by Region (2024-2029)
8 Latin America Ropivacaine Injection by Country
8.1 Latin America Ropivacaine Injection Historic Market Size by Country
8.1.1 Latin America Ropivacaine Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ropivacaine Injection Sales in Volume by Country (2018-2024)
8.1.3 Latin America Ropivacaine Injection Sales in Value by Country (2018-2024)
8.2 Latin America Ropivacaine Injection Forecasted Market Size by Country
8.2.1 Latin America Ropivacaine Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ropivacaine Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Ropivacaine Injection by Country
9.1 Middle East and Africa Ropivacaine Injection Historic Market Size by Country
9.1.1 Middle East and Africa Ropivacaine Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ropivacaine Injection Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Ropivacaine Injection Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Ropivacaine Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Ropivacaine Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ropivacaine Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Ropivacaine Injection Products Offered
10.1.5 Pfizer Recent Development
10.2 Akorn
10.2.1 Akorn Company Information
10.2.2 Akorn Introduction and Business Overview
10.2.3 Akorn Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Akorn Ropivacaine Injection Products Offered
10.2.5 Akorn Recent Development
10.3 Anant Pharmaceuticals
10.3.1 Anant Pharmaceuticals Company Information
10.3.2 Anant Pharmaceuticals Introduction and Business Overview
10.3.3 Anant Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Anant Pharmaceuticals Ropivacaine Injection Products Offered
10.3.5 Anant Pharmaceuticals Recent Development
10.4 SGPharma
10.4.1 SGPharma Company Information
10.4.2 SGPharma Introduction and Business Overview
10.4.3 SGPharma Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.4.4 SGPharma Ropivacaine Injection Products Offered
10.4.5 SGPharma Recent Development
10.5 Nephron Pharmaceuticals
10.5.1 Nephron Pharmaceuticals Company Information
10.5.2 Nephron Pharmaceuticals Introduction and Business Overview
10.5.3 Nephron Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Nephron Pharmaceuticals Ropivacaine Injection Products Offered
10.5.5 Nephron Pharmaceuticals Recent Development
10.6 Sintetica SA
10.6.1 Sintetica SA Company Information
10.6.2 Sintetica SA Introduction and Business Overview
10.6.3 Sintetica SA Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sintetica SA Ropivacaine Injection Products Offered
10.6.5 Sintetica SA Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Company Information
10.7.2 AstraZeneca Introduction and Business Overview
10.7.3 AstraZeneca Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.7.4 AstraZeneca Ropivacaine Injection Products Offered
10.7.5 AstraZeneca Recent Development
10.8 Manus Aktteva Biopharma LLP
10.8.1 Manus Aktteva Biopharma LLP Company Information
10.8.2 Manus Aktteva Biopharma LLP Introduction and Business Overview
10.8.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Products Offered
10.8.5 Manus Aktteva Biopharma LLP Recent Development
10.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
10.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
10.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Introduction and Business Overview
10.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Products Offered
10.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development
10.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
10.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information
10.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Introduction and Business Overview
10.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Products Offered
10.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Development
10.11 Yangzi River Pharmaceutical Group
10.11.1 Yangzi River Pharmaceutical Group Company Information
10.11.2 Yangzi River Pharmaceutical Group Introduction and Business Overview
10.11.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Products Offered
10.11.5 Yangzi River Pharmaceutical Group Recent Development
10.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
10.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Introduction and Business Overview
10.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Products Offered
10.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Development
10.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
10.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Information
10.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Introduction and Business Overview
10.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Products Offered
10.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ropivacaine Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ropivacaine Injection Industrial Chain Analysis
11.4 Ropivacaine Injection Market Dynamics
11.4.1 Ropivacaine Injection Industry Trends
11.4.2 Ropivacaine Injection Market Drivers
11.4.3 Ropivacaine Injection Market Challenges
11.4.4 Ropivacaine Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ropivacaine Injection Distributors
12.3 Ropivacaine Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 2 mg/mL (0.2%)
Table 2. Major Company of 5 mg/mL (0.5%)
Table 3. Major Company of 7.5 mg/mL (0.75%)
Table 4. Major Company of 10 mg/mL (1%)
Table 5. Global Ropivacaine Injection Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Ropivacaine Injection Sales by Type (2018-2024) & (K Units)
Table 7. Global Ropivacaine Injection Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Ropivacaine Injection Sales by Type (2018-2024) & (US& Million)
Table 9. Global Ropivacaine Injection Market Share in Value by Type (2018-2024)
Table 10. Global Ropivacaine Injection Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Ropivacaine Injection Sales by Type (2024-2029) & (K Units)
Table 12. Global Ropivacaine Injection Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Ropivacaine Injection Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Ropivacaine Injection Sales Market Share in Value by Type (2024-2029)
Table 15. Global Ropivacaine Injection Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Ropivacaine Injection Sales by Type (2018-2024) & (K Units)
Table 17. North America Ropivacaine Injection Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Ropivacaine Injection Sales (K Units) by Type (2018-2024)
Table 19. Europe Ropivacaine Injection Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Ropivacaine Injection Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Ropivacaine Injection Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Ropivacaine Injection Sales (K Units) by Type (2018-2024)
Table 23. Latin America Ropivacaine Injection Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Ropivacaine Injection Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Ropivacaine Injection Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Ropivacaine Injection Sales by Company (2018-2024) & (K Units)
Table 27. Global Ropivacaine Injection Sales Share by Company (2018-2024)
Table 28. Global Ropivacaine Injection Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Ropivacaine Injection Revenue Share by Company (2018-2024)
Table 30. Global Market Ropivacaine Injection Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Ropivacaine Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Ropivacaine Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ropivacaine Injection as of 2022)
Table 34. Date of Key Manufacturers Enter into Ropivacaine Injection Market
Table 35. Key Manufacturers Ropivacaine Injection Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Ropivacaine Injection Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Ropivacaine Injection Sales by Region (2018-2024) & (K Units)
Table 39. Global Ropivacaine Injection Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Ropivacaine Injection Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Ropivacaine Injection Sales Market Share in Value by Region (2018-2024)
Table 42. Global Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Ropivacaine Injection Sales by Region (2024-2029) & (K Units)
Table 44. Global Ropivacaine Injection Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Ropivacaine Injection Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Ropivacaine Injection Sales Market Share in Value by Region (2024-2029)
Table 47. Global Ropivacaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Ropivacaine Injection Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Ropivacaine Injection Sales by Application (2018-2024) & (K Units)
Table 50. Global Ropivacaine Injection Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Ropivacaine Injection Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Ropivacaine Injection Sales Market Share in Value by Application (2018-2024)
Table 53. Global Ropivacaine Injection Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Ropivacaine Injection Sales by Application (2024-2029) & (K Units)
Table 55. Global Ropivacaine Injection Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Ropivacaine Injection Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Ropivacaine Injection Sales Market Share in Value by Application (2024-2029)
Table 58. Global Ropivacaine Injection Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Ropivacaine Injection Sales by Application (2018-2024) (K Units)
Table 60. North America Ropivacaine Injection Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Ropivacaine Injection Sales by Application (2018-2024) (K Units)
Table 62. Europe Ropivacaine Injection Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Ropivacaine Injection Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Ropivacaine Injection Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Ropivacaine Injection Sales by Application (2018-2024) (K Units)
Table 66. Latin America Ropivacaine Injection Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Ropivacaine Injection Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Ropivacaine Injection Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Ropivacaine Injection Sales by Country (2018-2024) & (K Units)
Table 70. North America Ropivacaine Injection Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Ropivacaine Injection Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Ropivacaine Injection Sales Market Share in Value by Country (2018-2024)
Table 73. North America Ropivacaine Injection Sales by Country (2024-2029) & (K Units)
Table 74. North America Ropivacaine Injection Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Ropivacaine Injection Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Ropivacaine Injection Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Ropivacaine Injection Sales by Country (2018-2024) & (K Units)
Table 78. Europe Ropivacaine Injection Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Ropivacaine Injection Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Ropivacaine Injection Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Ropivacaine Injection Sales by Country (2024-2029) & (K Units)
Table 82. Europe Ropivacaine Injection Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Ropivacaine Injection Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Ropivacaine Injection Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Ropivacaine Injection Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Ropivacaine Injection Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Ropivacaine Injection Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Ropivacaine Injection Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Ropivacaine Injection Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Ropivacaine Injection Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Ropivacaine Injection Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Ropivacaine Injection Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Ropivacaine Injection Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Ropivacaine Injection Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Ropivacaine Injection Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Ropivacaine Injection Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Ropivacaine Injection Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Ropivacaine Injection Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Ropivacaine Injection Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Ropivacaine Injection Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Ropivacaine Injection Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Ropivacaine Injection Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Ropivacaine Injection Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Ropivacaine Injection Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Ropivacaine Injection Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Ropivacaine Injection Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Ropivacaine Injection Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Ropivacaine Injection Sales Market Share in Value by Country (2024-2029)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Ropivacaine Injection Product
Table 113. Pfizer Recent Development
Table 114. Akorn Company Information
Table 115. Akorn Introduction and Business Overview
Table 116. Akorn Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Akorn Ropivacaine Injection Product
Table 118. Akorn Recent Development
Table 119. Anant Pharmaceuticals Company Information
Table 120. Anant Pharmaceuticals Introduction and Business Overview
Table 121. Anant Pharmaceuticals Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Anant Pharmaceuticals Ropivacaine Injection Product
Table 123. Anant Pharmaceuticals Recent Development
Table 124. SGPharma Company Information
Table 125. SGPharma Introduction and Business Overview
Table 126. SGPharma Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. SGPharma Ropivacaine Injection Product
Table 128. SGPharma Recent Development
Table 129. Nephron Pharmaceuticals Company Information
Table 130. Nephron Pharmaceuticals Introduction and Business Overview
Table 131. Nephron Pharmaceuticals Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Nephron Pharmaceuticals Ropivacaine Injection Product
Table 133. Nephron Pharmaceuticals Recent Development
Table 134. Sintetica SA Company Information
Table 135. Sintetica SA Introduction and Business Overview
Table 136. Sintetica SA Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Sintetica SA Ropivacaine Injection Product
Table 138. Sintetica SA Recent Development
Table 139. AstraZeneca Company Information
Table 140. AstraZeneca Introduction and Business Overview
Table 141. AstraZeneca Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. AstraZeneca Ropivacaine Injection Product
Table 143. AstraZeneca Recent Development
Table 144. Manus Aktteva Biopharma LLP Company Information
Table 145. Manus Aktteva Biopharma LLP Introduction and Business Overview
Table 146. Manus Aktteva Biopharma LLP Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Manus Aktteva Biopharma LLP Ropivacaine Injection Product
Table 148. Manus Aktteva Biopharma LLP Recent Development
Table 149. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
Table 150. Zhejiang Xianju Pharmaceutical Co.,Ltd Introduction and Business Overview
Table 151. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product
Table 153. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development
Table 154. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information
Table 155. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Introduction and Business Overview
Table 156. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product
Table 158. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Development
Table 159. Yangzi River Pharmaceutical Group Company Information
Table 160. Yangzi River Pharmaceutical Group Introduction and Business Overview
Table 161. Yangzi River Pharmaceutical Group Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Yangzi River Pharmaceutical Group Ropivacaine Injection Product
Table 163. Yangzi River Pharmaceutical Group Recent Development
Table 164. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
Table 165. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Introduction and Business Overview
Table 166. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product
Table 168. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Development
Table 169. Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Information
Table 170. Jiangsu Nhwa Pharmaceutical Co.,Ltd Introduction and Business Overview
Table 171. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product
Table 173. Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Ropivacaine Injection Market Trends
Table 177. Ropivacaine Injection Market Drivers
Table 178. Ropivacaine Injection Market Challenges
Table 179. Ropivacaine Injection Market Restraints
Table 180. Ropivacaine Injection Distributors List
Table 181. Ropivacaine Injection Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Ropivacaine Injection Product Picture
Figure 2. Global Ropivacaine Injection Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Ropivacaine Injection Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Ropivacaine Injection Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 2 mg/mL (0.2%)
Figure 6. Global 2 mg/mL (0.2%) Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 5 mg/mL (0.5%)
Figure 8. Global 5 mg/mL (0.5%) Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 7.5 mg/mL (0.75%)
Figure 10. Global 7.5 mg/mL (0.75%) Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of 10 mg/mL (1%)
Figure 12. Global 10 mg/mL (1%) Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Ropivacaine Injection Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Ropivacaine Injection Sales Market Share by Type in 2022 & 2029
Figure 15. North America Ropivacaine Injection Sales Market Share in Volume by Type in 2022
Figure 16. North America Ropivacaine Injection Sales Market Share in Value by Type in 2022
Figure 17. Europe Ropivacaine Injection Sales Market Share in Volume by Type in 2022
Figure 18. Europe Ropivacaine Injection Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Ropivacaine Injection Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Ropivacaine Injection Sales Market Share in Value by Type in 2022
Figure 21. Latin America Ropivacaine Injection Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Ropivacaine Injection Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Ropivacaine Injection Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Ropivacaine Injection Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Ropivacaine Injection Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Ropivacaine Injection Revenue in 2022
Figure 27. Ropivacaine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Surgical Anesthesia
Figure 29. Global Surgical Anesthesia Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Major Nerve Block
Figure 31. Global Major Nerve Block Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Acute Pain Management
Figure 33. Global Acute Pain Management Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Ropivacaine Injection Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Ropivacaine Injection Sales Market Share by Application in 2022 & 2029
Figure 38. North America Ropivacaine Injection Sales Market Share in Volume by Application in 2022
Figure 39. North America Ropivacaine Injection Sales Market Share in Value by Application in 2022
Figure 40. Europe Ropivacaine Injection Sales Market Share in Volume by Application in 2022
Figure 41. Europe Ropivacaine Injection Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Ropivacaine Injection Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Ropivacaine Injection Sales Market Share in Value by Application in 2022
Figure 44. Latin America Ropivacaine Injection Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Ropivacaine Injection Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Ropivacaine Injection Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Ropivacaine Injection Manufacturing Cost Structure
Figure 49. Ropivacaine Injection Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries